Michael Kaufman
2018
In 2018, Michael Kaufman earned a total compensation of $951.8K as Chief Manufacturing Officer at Mersana Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $119,250 |
|---|---|
| Option Awards | $470,511 |
| Salary | $356,000 |
| Other | $6,000 |
| Total | $951,761 |
Kaufman received $470.5K in option awards, accounting for 49% of the total pay in 2018.
Kaufman also received $119.3K in non-equity incentive plan, $356K in salary and $6K in other compensation.
Rankings
In 2018, Michael Kaufman's compensation ranked 9,443rd out of 14,244 executives tracked by ExecPay. In other words, Kaufman earned more than 33.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,443 out of 14,244 | 34th |
Division Manufacturing | 3,792 out of 5,765 | 34th |
Major group Chemicals And Allied Products | 1,428 out of 2,128 | 33rd |
Industry group Drugs | 1,203 out of 1,817 | 34th |
Industry Pharmaceutical Preparations | 931 out of 1,391 | 33rd |
Source: SEC filing on April 27, 2021.
Kaufman's colleagues
We found three more compensation records of executives who worked with Michael Kaufman at Mersana Therapeutics in 2018.
News
Mersana Therapeutics CEO Anna Protopapas' 2021 pay jumps 226% to $8.3M
April 29, 2022
Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
April 27, 2021
Mersana Therapeutics CEO Anna Protopapas' 2019 pay falls 33% to $1.7M
April 20, 2020
Mersana Therapeutics CEO Anna Protopapas' 2018 pay jumps 184% to $2.6M
April 23, 2019